Literature DB >> 4959545

The prophylactic use of thio-TEPA in transitional cell carcinoma of the bladder.

J W Wescott.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 4959545     DOI： 10.1016/s0022-5347(17)63381-0

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  6 in total

1.  Local application of THIO-TEPA in the prevention of recurrent papillary carcinoma of the bladder.

Authors:  M Csellár; A Csontai
Journal:  Int Urol Nephrol       Date:  1979       Impact factor: 2.370

2.  The prophylactic use of Thio-TEPA, an adjuvant in the treatment of bladder tumours.

Authors:  W Dobrzecki; A Kaczmarek
Journal:  Int Urol Nephrol       Date:  1977       Impact factor: 2.370

Review 3.  Intravesical chemotherapy in the United States. An overview.

Authors:  J T Spaulding
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

4.  Early onset life-threatening myelosuppression after low dose of intravesical thiotepa.

Authors:  G Agnelli; M de Cunto; P Gresele; A del Favero
Journal:  Postgrad Med J       Date:  1982-06       Impact factor: 2.401

5.  Bladder hyperthermia in the treatment of vesical papillomatosis.

Authors:  G Lunglmayr; K Czech; F Zekert; G Kellner
Journal:  Int Urol Nephrol       Date:  1973-01       Impact factor: 2.370

6.  Minimization of inflammation in the treatment of bladder tumors by intravesical instillation of adriamycin.

Authors:  Y Ohi; K Okamoto; T Kawabata; A Hanafusa; C Y Fai; T Kakinoki; M Kawahara; S Asechi; N Sakamoto; S Nagata
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.